Information regarding the total number of voting rights and total number of shares of the Company as of May 30, 2025
(Article 223-16 of the General Regulations of the Autorité des Marchés Financiers)
Market : NYSE Euronext Paris
ISIN Code: FR 0010417345
Date | Total number of shares | Total number of voting rights |
| 05/30/2025 | 136,973,697 | Total gross of voting rights: 136,973,697 |
Total net* of voting rights: 136,738,528 |
* Net total = total number of voting rights attached to shares – shares without voting rights
| Last Trade: | US$9.27 |
| Daily Change: | -0.21 -2.22 |
| Daily Volume: | 24,833 |
| Market Cap: | US$253.600M |
July 22, 2025 | |
Cue Biopharma is developing the first-ever class of therapeutics for the treatment of cancer that mimic the natural signals, or “Cues”, of the immune system. This novel class of injectable biologics selectively engages and modulates tumor-specific T cells directly within the patient’s body to transform...
CLICK TO LEARN MORE
Amneal Pharmaceuticals is a fully-integrated essential medicines company. We make healthy possible through the development, manufacturing, and distribution of generic and specialty pharmaceuticals. The Company has a diverse portfolio of over 250 products in its Generics segment and is expanding across...
CLICK TO LEARN MORE
